CMCC Patient Advisory Committee Marks First for Medical Cannabis Industry

TORONTO, ONTARIO--(Marketwired - Sept. 2, 2015) - Today, the Canadian Medical Cannabis Council (CMCC) announced the launch of the medical cannabis industry's first Patient Advisory Committee (PAC). The Committee, which is comprised of leading patient groups from across Canada, will work to ensure patients and their best interests are the focus of the practices, activities and policy advocacy of CMCC.

The group currently includes representatives of the Canadian AIDS Society (CAS), The Arthritis Society, Canadians for Fair Access to Medical Marijuana (CFAMM), the Improving the Life of Children (ILC) Foundation and The Wellness Soldier. Over the coming months, CMCC will be recruiting additional members to join the PAC.

CMCC's Interim Executive Director, Philippe Lucas, offered the following remarks about the importance of PAC:

  • "This is a historic announcement. With the patient advisory committee, CMCC is working to help put patients, rightfully, at the centre of the discussion about the future
  • ...
Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.